XSHE
002311
Market cap10bUSD
Jul 09, Last price
44.60CNY
1D
-2.19%
1Q
-8.42%
Jan 2017
196.35%
IPO
274.79%
Name
Guangdong Haid Group Co.
Chart & Performance
P/E
17.14
P/S
0.57
EPS
2.60
Div Yield, %
2.91%
Shrs. gr., 5y
1.10%
Rev. gr., 5y
16.32%
Revenues
128.47b
+12.10%
Net income
4.28b
-4.97%
CFO
6.26b
-21.71%
Dividend
Sep 25, 20250.2 CNY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Guangdong Haid Group Co., Limited, together with its subsidiaries, research, develops, designs, produces, sells, and services animal feed products in China and internationally. The company operates through Feed, Animal Health, Farming, and Trading segments. It offers animal feeds, such as chickens, ducks, geese, pigs, fishes, shrimps, crabs, and ruminants; farmed varieties, including live pigs, shrimps, and fishes; and seedlings comprising shrimp fry and fish fry. The company also provides animal health products, such as biological products, veterinary drugs, and vaccines required in the livestock and poultry, and aquaculture processes. In addition, it offers pre-prepared aquatic dishes, as well as livestock and poultry products. Guangdong Haid Group Co., Limited was incorporated in 1998 and is headquartered in Guangzhou, China. Guangdong Haid Group Co., Limited operates as a subsidiary of Guangzhou Haihao Investment Co., Ltd.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||